IL13R alpha 2 CAR-T by TCR Cure Biopharma Technology for Glioma: Likelihood of Approval

IL13R alpha 2 CAR-T is under clinical development by TCR Cure Biopharma Technology and currently in Phase I for Glioma.

High aerobic fitness at age 18 linked to lower risk of several types of cancer

Men who have higher aerobic fitness at age 18 have a lower risk of several forms of cancer later in life, especially cancers of the

August 16, 2023

MHRA approves Pfizer-BioNTech’s adapted vaccine for Covid-19

The MHRA approved Pfizer and BioNTech’s Covid-19 vaccine after validating its safety, quality and effectiveness. Credit: InFocus.ee/Shutterstock.com. The UK Medicines and Healthcare products Regulatory Agency

September 6, 2023

Butterfly iQ3 Takes Flight: Next-Gen Handheld Ultrasound Cleared by FDA

by Syed Hamza Sohail 01/09/2024 Leave a Comment What You Should Know: Butterfly Network, Inc. (“Butterfly”), a digital health company transforming care through the power

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.